A clinical update on psoriatic arthritis diagnosis and oral therapy, highlighting JAK/STAT pathogenesis, apremilast (PALACE), deucravacitinib (POETYK PsA-1/2), methotrexate safety concerns, and individualized treatment strategies.
A clinical update on psoriatic arthritis diagnosis and oral therapy, highlighting JAK/STAT pathogenesis, apremilast (PALACE), deucravacitinib (POETYK PsA-1/2), methotrexate safety concerns, and individualized treatment strategies.
A clinical update on psoriatic...